Plancorp LLC’s AbbVie ABBV Stock Holding History

Plancorp LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.02M	Sell	16,225 -992	-6%	-$213K	0.1%	90
2026 Q1	$3.58M	Buy	17,217 +13	+0.1%	+$2.88K	0.1%	78
2025 Q4	$3.93M	Sell	17,204 -48	-0.3%	-$10.9K	0.12%	69
2025 Q3	$3.99M	Sell	17,252 -853	-5%	-$174K	0.13%	71
2025 Q2	$3.36M	Buy	18,105 +340	+2%	+$63.2K	0.12%	72
2025 Q1	$3.72M	Buy	17,765 +1,210	+7%	+$235K	0.15%	59
2024 Q4	$2.94M	Buy	16,555 +1,250	+8%	+$230K	0.12%	62
2024 Q3	$3.02M	Sell	15,305 -141	-0.9%	-$26.3K	0.12%	63
2024 Q2	$2.65M	Sell	15,446 -496	-3%	-$82.2K	0.11%	65
2024 Q1	$2.9M	Buy	15,942 +630	+4%	+$109K	0.13%	63
2023 Q4	$2.37M	Buy	15,312 +273	+2%	+$39.8K	0.11%	69
2023 Q3	$2.24M	Buy	15,039 +708	+5%	+$104K	0.12%	66
2023 Q2	$1.93M	Buy	14,331 +248	+2%	+$36.4K	0.1%	72
2023 Q1	$2.24M	Sell	14,083 -2	-0%	-$306	0.13%	62
2022 Q4	$2.28M	Sell	14,085 -74	-0.5%	-$11.3K	0.13%	59
2022 Q3	$1.9M	Sell	14,159 -162	-1%	-$23.2K	0.13%	60
2022 Q2	$2.19M	Buy	14,321 +360	+3%	+$55K	0.14%	58
2022 Q1	$2.26M	Buy	13,961 +665	+5%	+$96.6K	0.15%	58
2021 Q4	$1.8M	Buy	13,296 +256	+2%	+$30.2K	0.11%	74
2021 Q3	$1.41M	Sell	13,040 -61	-0.5%	-$6.97K	0.1%	73
2021 Q2	$1.48M	Sell	13,101 -81	-0.6%	-$9.12K	0.12%	67
2021 Q1	$1.43M	Sell	13,182 -465	-3%	-$49.7K	0.31%	59
2020 Q4	$1.46M	Buy	13,647 +697	+5%	+$67K	0.36%	54
2020 Q3	$1.13M	Sell	12,950 -1,063	-8%	-$100K	0.34%	55
2020 Q2	$1.38M	Buy	14,013 +2,171	+18%	+$191K	0.41%	50
2020 Q1	$902K	Buy	11,842 +136	+1%	+$11.6K	0.35%	56
2019 Q4	$1.04M	Buy	11,706 +5,507	+89%	+$457K	0.32%	61
2019 Q3	$469K	Sell	6,199 -52	-0.8%	-$3.56K	0.18%	97
2019 Q2	$455K	Sell	6,251 -12,461	-67%	-$979K	0.18%	99
2019 Q1	$1.51M	Buy	18,712 +528	+3%	+$43.2K	0.57%	44
2018 Q4	$1.68M	Sell	18,184 -266	-1%	-$23.4K	0.76%	28
2018 Q3	$1.75M	Sell	18,450 -262	-1%	-$24.8K	0.69%	34
2018 Q2	$1.73M	Buy	18,712 +543	+3%	+$53K	0.69%	32
2018 Q1	$1.72M	Sell	18,169 -175	-1%	-$19.2K	0.55%	33
2017 Q4	$1.77M	Buy	18,344 +21	+0.1%	+$1.98K	0.58%	35
2017 Q3	$1.63M	Sell	18,323 -5,915	-24%	-$450K	0.48%	37
2017 Q2	$1.76M	Buy	24,238 +4	+0%	+$269	0.52%	36
2017 Q1	$1.58M	Buy	24,234 +226	+0.9%	+$14.2K	0.46%	39
2016 Q4	$1.5M	Buy	24,008 +123	+0.5%	+$7.51K	0.43%	38
2016 Q3	$1.51M	Buy	23,885 +11,732	+97%	+$759K	0.96%	30
2016 Q2	$752K	Buy	12,153 +6,153	+103%	+$375K	0.67%	29
2016 Q1	$342K	Sell	6,000 -6,153	-51%	-$343K	0.41%	31
2015 Q4	$720K	Hold	12,153	–	–	0.86%	29
2015 Q3	$661K	Buy	12,153 +6,153	+103%	+$401K	0.6%	40
2015 Q2	$404K	Sell	6,000 -8,366	-58%	-$546K	0.37%	50
2015 Q1	$841K	Buy	+14,366	New	+$868K	0.84%	28
2014 Q4	–	Sell	-10,867	Closed	-$627K	–	69
2014 Q3	$627K	Buy	+10,867	New	+$603K	0.66%	34
2014 Q2	–	Sell	-12,079	Closed	-$619K	–	74
2014 Q1	$619K	Buy	12,079 +1,742	+17%	+$88K	0.42%	48
2013 Q4	$546K	Buy	+10,337	New	+$508K	0.48%	42

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Plancorp LLC's ABBV Position: Q2 2026 in Review

Plancorp LLC reduced its AbbVie (ABBV) stake by 5.8% in Q2 2026, selling an estimated $213K and leaving 16,225 shares worth $4.02M. The position accounts for 0.1% of the portfolio, ranked #90.

Plancorp LLC first reported a position in ABBV in Q4 2013 and has held it in 49 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Plancorp LLC held 16,225 shares of AbbVie worth $4.02M as of Q2 2026.
Plancorp LLC sold 992 AbbVie shares in Q2 2026, an estimated $213K.
AbbVie made up 0.1% of Plancorp LLC's portfolio in Q2 2026, its #90 holding.
Plancorp LLC first reported a position in AbbVie in Q4 2013 and has held it in 49 quarters since.
1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Plancorp LLC's 13F filing for Q2 2026, filed 14 Jul 2026.